AMGN · Amgen Inc

$415.21 -2.63 (-0.63%) At close · Aug 14

Market Cap

$224.48B

540.63M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Bradway	Chief Executive Officer and President	$1,869,242	$0	$12,599,930	$5,399,991	$3,845,000	$714,332	$24,428,495
James Bradner	Executive Vice President, Research and Development	$1,214,331	$1,021,429	$9,528,772	$1,289,932	$1,661,000	$198,917	$14,914,381
Murdo Gordon	Executive Vice President, Global Commercial Operations	$1,197,268	$0	$3,709,504	$1,589,966	$1,642,000	$334,762	$8,473,500
David Reese	CTO	$1,268,615	$0	$3,359,613	$1,439,984	$1,740,000	$318,610	$8,126,822
David M. Reese, M.D.	Executive Vice President, and Chief Technology Officer	$1,268,615	$0	$3,359,613	$1,439,984	$1,740,000	$318,610	$8,126,822
Peter Griffith	Executive Vice President and Chief Financial Officer	$1,133,633	$0	$3,359,613	$1,439,984	$1,555,000	$318,581	$7,806,811

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Bradway	Chief Executive Officer and President	$1,786,977	$0	$11,138,503	$4,773,714	$4,264,000	$680,456	$22,643,650
Murdo Gordon	Executive Vice President, Global Commercial Operations	$1,144,623	$0	$3,499,708	$1,499,969	$1,821,000	$277,511	$8,242,811
David M. Reese, M.D.	Executive Vice President, and Chief Technology Officer	$1,212,823	$0	$3,149,928	$1,349,985	$1,929,000	$260,919	$7,902,655
David Reese	CTO	$1,212,823	$0	$3,149,928	$1,349,985	$1,929,000	$260,919	$7,902,655
Peter Griffith	Executive Vice President and Chief Financial Officer	$1,083,762	$0	$3,149,928	$1,349,985	$1,724,000	$261,623	$7,569,298

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Bradway	Chief Executive Officer and President	$1,722,300	$0	$11,138,544	$4,773,714	$3,122,000	$643,175	$21,399,733
Murdo Gordon	Executive Vice President, Global Commercial Operations	$1,103,277	$0	$3,499,679	$1,499,985	$1,333,000	$281,285	$7,717,226
David M. Reese, M.D.	Executive Vice President, and Chief Technology Officer	$1,158,846	$0	$3,149,736	$1,349,995	$1,397,000	$277,547	$7,333,124
David Reese	CTO	$1,158,846	$0	$3,149,736	$1,349,995	$1,397,000	$277,547	$7,333,124
Peter Griffith	Executive Vice President and Chief Financial Officer	$1,044,492	$0	$3,149,736	$1,349,995	$1,262,000	$267,512	$7,073,735

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Esteban Santos	Executive Vice President, Operations	$978,446	$0	$2,799,625	$1,199,958	$1,384,000	$229,624	$6,591,653
Peter Griffith	Executive Vice President, and Chief Financial Officer	$998,864	$0	$2,799,625	$1,199,958	$1,413,000	$154,383	$6,565,830

Executive changes

Person	Role	Change	Effective	Filed
Thomas Dittrich	Executive Vice President and Chief Financial Officer	Appointed	2026-09-01	2026-05-19
Sean Bruich	senior vice president, Chief Technology Officer	Appointed	2026-06-01	2026-04-22
David M. Reese	Executive Vice President	Retired	2026-06-30	2026-04-22
David M. Reese	Executive Vice President and Chief Technology Officer	Retired	2026-06-30	2026-04-22
James Bradner, M.D.	Executive Vice President, Research and Development, and Chief Scientific Officer	Appointed	2023-12-18	2023-12-14
David M. Reese, M.D.	Executive Vice President and Chief Technology Officer	Appointed	2023-12-18	2023-12-14
Matthew C. Busch	Vice President, Finance and Chief Accounting Officer	Appointed	2023-08-14	2023-08-04
Michael V. Drake	director	Appointed	2022-08-03	2022-08-03

Key facts CIK 318154 CUSIP 031162100 13F (30d) 2653 filings 2586 filers Visit website Investor relations